Recombinant PSG1 Protein, Human (Fc Tag) Recombinant Proteins The human PSG1 (NP_001171754.1) (Met1-Pro419) was expressed with the Fc region of human IgG1 at the C-terminus The recombinant human PSG1 consists 623a.a and predicts a molecular weight of 70.2 kDa.
$ $99 In stock
Formulation: The recombinant human PSG1 consists 623a.a and predicts a molecular weight of 70.2 kDa.
Source: HEK293 Cells
Usage: Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use

Recombinant PSG1 Protein, Human (Fc Tag)

Formulation: Recombinant PSG1 Protein was lyophilized from sterile PBS, pH 7.4.1

Source: HEK293 Cells

Product Name Recombinant PSG1 Protein, Human (Fc Tag)
Product Type Recombinant Protein
Source HEK293 Cells
Formulation Recombinant PSG1 Protein was lyophilized from sterile PBS, pH 7.4.1
Molecular Weight The recombinant human PSG1 consists 623a.a and predicts a molecular weight of 70.2 kDa.
Endotoxin < 1.0 EU per μg protein as determined by the LAL method
Purity Greater than 85% as determined by SDS-PAGE.
Description The human PSG1 (NP_001171754.1) (Met1-Pro419) was expressed with the Fc region of human IgG1 at the C-terminus
Host Species Homo sapiens (Human)
Usage Our products are for research use only. This product is not intended or approved for human, diagnostics or veterinary use
Storage Store recombinant protein under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
AA Sequence Met1-Pro419
Product Background Pregnancy-specific glycoproteins (PSGs) are a family of Ig-like proteins secreted by specialized placental cells. The PSG1 structure is composed of a single Ig variable region-like N-terminal domain and three Ig constant region-like domains termed A1, A2, and B2. Members of the human and murine PSG family have been shown to induce anti-inflammatory cytokines from monocytes and macrophages and to stimulate angiogenesis.Two distinct domains of PSG1 are involved in the regulation of TGF-beta1 and provide a mechanistic framework for how PSGs modulate the immunoregulatory environment at the maternal-fetal interface for successful pregnancy outcome.
Memo B1G1 Protein, Human;CD66f Protein, Human;DHFRP2 Protein, Human;FL-NCA-1/2 Protein, Human;PBG1 Protein, Human;PS-beta-C/D Protein, Human;PS-beta-G-1 Protein, Human;PSBG-1 Protein, Human;PSBG1 Protein, Human;PSG95 Protein, Human;PSGGA Protein, Human;PS
Terminal Gln 35
Bioactivity Please contact us for detailed information